Trimeris Shifts Focus Away From Fuzeon, Toward Pipeline Diversity
This article was originally published in The Pink Sheet Daily
Executive Summary
Restructuring plan, expected to wrap up by early 2007, will transfer some Fuzeon marketing responsibilities to Roche.